German B2B marine biomanufacturing company producing cultivated marine ingredients from fish cells for food, health, and personal care.
Last updated September 28, 2026
AI crawler reads
2requests
1companies- Anthropic2
- Profile
- 2
- Controversies
- 0
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
Bluu (also referred to as Bluu GmbH) is a German B2B ingredient company that develops marine ingredients through controlled biomanufacturing. According to its official website, the company uses a single fish-cell platform to produce ingredients for three main categories: food (cell-based seafood ingredients), health (marine bio-actives), and personal care (marine actives for premium skincare). The company positions itself as a partner-led platform, working with partners who formulate, commercialize, and scale products, rather than selling directly to consumers. Bluu's technology is based on cultivating fish cells in controlled bioreactor environments, which the company says allows it to produce marine ingredients without relying on oceans, seasons, or extraction. The company reports having achieved the world's first 1000L production with a partner, with a next milestone of 2000L targeted for 2027. It states it has raised over €30 million from a mix of private capital and public support, and claims cost reductions of more than 80% driven by process optimization and media improvements. The company describes itself as science-led and scale-minded, with a multidisciplinary team combining scientific expertise with biomanufacturing and scale-up. Its team includes roles such as Head of Human Resources, Head of Media Development, and scientists in bioprocess development and data analytics. Bluu is headquartered in Germany and operates as a private company. It is recognized and supported by various funding and grant programs and industry programs, according to its About page. Bluu's business model is B2B: it collaborates with ingredient and product companies rather than marketing its own consumer brands. Its food category is described as a long-term opportunity with a regulatory pathway established, while its personal care actives are already in active partner evaluations. The company emphasizes documentation-first collaboration and credible evaluation for its health bio-actives.
History
Bluu is a German company that develops concepts and technologies for the production of food and ingredients from animal cells, according to its Wikidata entry. The company has focused on marine biomanufacturing, using fish cells to produce ingredients for food, health, and personal care applications. On its official website, Bluu states that it has completed the world's first 1000L production achieved with a partner, with a next milestone of 2000L in 2027. The company reports having raised over €30 million from a mix of private capital and public support, aligned with long-term industrial development. It also claims cost reductions of more than 80% driven by process optimization and ongoing media improvements. Bluu describes itself as a B2B ingredient company working with partners who formulate, commercialize, and scale products. Its platform is designed to produce marine ingredients without relying on oceans, seasons, or extraction. The company has established a regulatory pathway for its cell-based seafood ingredients and has been first to market with active partner evaluations for personal care actives. Its health bio-actives are developed for credible evaluation and documentation-first collaboration. The company's team combines scientific expertise with biomanufacturing, scale-up, and execution. Key team members include Katharina Fricke (Head of Human Resources), Dr. Niraimathi Govindasamy (Head of Media Development), and scientists in bioprocess development and data analytics. Bluu has been recognized and supported by past and current funding and grants, awards, and industry programs.
Completed the world's first 1000L production achieved with partner
Next milestone: 2000L in 2027
Raised over €30M from private capital and public support
Achieved >80% cost reduction through process optimization and media improvements
Products and positioning
B2B marine biomanufacturing platform for consistent, scalable marine ingredients without ocean extraction.
Cell-based seafood ingredients
Long-term opportunity with regulatory pathway established.
Marine bio-actives for health
Developed for credible evaluation and documentation-first collaboration.
Marine actives for personal care
For premium skincare; first to market with active partner evaluations.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/bluu · Editorial policy · How profiles are compiled